RU-486

GPTKB entity

Statements (66)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:activities antiprogestin
gptkbp:appointed_by oral tablet
gptkbp:approves gptkb:1988
gptkb:Monarch
gptkb:United_States
gptkbp:associated_with feminist movements
gptkbp:availability worldwide
gptkbp:brand gptkb:Korlym
gptkb:Mifeprex
gptkbp:can_be_used_with ultrasound
gptkbp:caused_by gptkb:healthcare_organization
sepsis
heavy bleeding
gptkbp:clinical_trial Phase III
gptkbp:collaborated_with misoprostol
gptkbp:contraindication ectopic pregnancy
coagulation disorders
adrenal failure
gptkbp:developed_by gptkb:1980s
gptkb:Roussel-Uclaf
https://www.w3.org/2000/01/rdf-schema#label RU-486
gptkbp:impact reproductive rights
gptkbp:influenced_by gptkb:municipality
legal regulations
gptkbp:ingredients C21 H25 N O2
gptkbp:is gptkb:drug
gptkbp:is_associated_with patient education
gptkbp:is_atype_of G03 X B01
gptkbp:is_available_in many countries
gptkbp:is_challenged_by opposition groups
gptkbp:is_considered safe and effective
a landmark drug
gptkbp:is_discussed_in gptkb:academic_journal
legal debates
ethical discussions
gptkbp:is_linked_to gptkb:healthcare_organization
patient autonomy
gptkbp:is_part_of women's health care
abortion access discussions
abortion regimen
gptkbp:is_promoted_by advocacy groups
gptkbp:is_subject_to regulatory oversight
political scrutiny
gptkbp:is_used_by healthcare providers
gptkbp:is_used_for medical abortion
gptkbp:is_used_in clinical settings
gptkbp:legal_issue prescription only
gptkbp:marketed_as gptkb:Danco_Laboratories
gptkbp:regulates gptkb:FDA
gptkb:European_Medicines_Agency
gptkbp:related_to progesterone
progestin
gptkbp:requires informed consent
medical evaluation
gptkbp:side_effect nausea
abdominal pain
vomiting
diarrhea
gptkbp:suitable_for women over 35 who smoke
women with certain health conditions
gptkbp:type_of 84371-65-3
gptkbp:used_in medication abortion
early pregnancy termination
gptkbp:bfsParent gptkb:Plan_B
gptkbp:bfsLayer 4